|
|
 |
|
Lee H. Lytton, III
Professor Lee Lytton graduated from St. Mary’s Law
School (San Antonio, TX) with High Honors in 1968. Following
graduation, he served as briefing attorney to the late Judge
K.K. Woodley, Presiding Judge of the Texas Court of Criminal
Appeals. He was a Special Agent for the Federal Bureau of
Investigation, subsequently joining the St. Mary’s law faculty
at the behest of Dean James N. Castleberry in January 1987. He
has published a book on Texas Real Property Law and he has
served as a member of the Institutional Review Board of
Southwest Methodist Hospital in San Antonio; and he is a ten
year member of the Board of Directors of Fairway Medical
Technologies, Inc.
|
 |
|
William McLucas
William McLucas is currently
President of Medical Center laboratory LLP II, Houston Texas.
(MCL). MCL is a provider of full service clinical laboratories
to all aspects of the Houston medical community. From November
1, 2003 to January 15, 2006 he was President of mergers and
acquisitions for Clinical Labs USA, of Houston Texas (CLUSA).
This company is a full service medical laboratory providing
work to the long term care industry. The company was conceived
and developed by a group of lab owners and an investment
banki^l g group. It became one of the largest privately held
laboratories in the southwest. From June, 1986 to
November, 2003 he was President and CEO of Alliance Clinical
Laboratories. This company was built and started in Houston
Texas. At the time of its merger with Clinical labs USA, it
had offices in six cities, three hundred workers and sales in
excess of twelve million dollars. Beginning in January,
1983 throughout June 1986 Mr. McLucas was Founder and
President of National Medical Financial Services (NMFS). NMFS
was a home healthcare company that specialized in the sale of
durable medical equipment. The company sales included the sale
of all types of home use walkers, wheelchairs, hospital beds
and home use medical needs. The company was also a provider of
continuous use oxygen for people with respiratory failure.
NMFS was sold to a public company in 1986. Mr. McLucas
developed a program for veterinary laboratory service for
clinics throughout the country. Based in Houston, it serviced
over twenty five hundred veterinarians from our Lab. With
sales of over four million dollars the lab was sold to Vet
Centers of America, a public company.
|
 |
|
D. Bradley McWilliams
Mr. D. Bradley McWilliams, a Certified Public
Accountant and Attorney at Law received his BBA and JD
requires at the University of Texas (Austin). He did post
graduate work at New York University and Harvard University.
He spent 32 Years with Cooper Industries LTD, (CBE – NYSE),
and retired as their chief Financial officer in 2003, after 32
years of service Mr. McWilliams has served on many corporate
boards both for profit and non-profit boards, he is a life
member of the Board of the YMCA of the Greater Houston area
Inc. (which includes 42 branches in the greater Houston area)
and he recently joined the University of Texas Health Science
Center at Houston (UT- Houston) development board. Mr.
McWilliams currently serve as a Board member, chairman of the
Audit committee and a member of the Finance committee of
McDermott International Inc. (MDR – NYSE); Mr. McWilliams is a
major shareholder and
member of The Board of Directors of
Fairway Medical Technologies Inc.
|
 |
|
James W. Meador
Jim is a Mechanical Engineer and has founded three
medical companies. He has over 25 years Executive experience
with medical device companies and has brought over 25 medical
devices to market. Jim has over 24 years of innovative medical
product development experience. Scientifically published, and
a holder of over 50 U.S. & foreign patents, he is
experienced in medical product development in a diversity of
market areas including: cardiovascular, immunology,
microbiology, hematology, rehabilitation, drug-abuse, and a
variety of specialty consulting areas. He co-founded KVM
Technologies in 1977 and acted as Executive Vice President and
Manager for the contract medical product development aspects
of the company. This group brought over 40 medical products to
market. He was also the Director of Operations for KVM
Rehabilitation, a marketing and sales subsidiary of KVM that
was sold in 1994. Prior to KVM he was in charge of engineering
for the Total Artificial Heart Program at the Texas Heart
Institute. He was a member of the Baylor/Rice Artificial Heart
Program while attending Rice University where he received his
BS in Mechanical and Aerospace Engineering degree. Jim is
currently the President and CEO of Cormedics, a Fairway
Portfolio Company.
|
 |
|
Morteza Naghavi, M.D.
Dr. Naghavi is an innovative physician scientist
in the fields of cardiovascular medicine and medical
technologies. He has founded four medical companies and is
internationally recognized as a leader in heart attack
prevention initiatives. As a former cardiology faculty at the
University of Texas Health Science Center in Houston and
Co-Director of the Vulnerable Plaque Research Department at
the Texas Heart Institute, he made several inventions and
contributed to creating the field of “Vulnerable Plaque”, the
immediate underlying cause of heart attacks. Pioneering work
by Dr. Naghavi and colleagues at the Texas Heart Institute led
to the foundation of Volcano Corporation (NASDAQ: VOLC), a
leading cardiovascular diagnostic company. Following the
successful public offering of Volcano Corporation in 2006, Dr.
Naghavi founded and invested in several startup companies
including Endothelix Inc., ThermaRx Inc., IC Therapeutics
Inc., and Personalized Weight Management Inc. Through his
years of leadership in the field of early detection and
prevention of cardiovascular disease, Dr. Naghavi founded the
Society for Heart Attack Prevention and Eradication (SHAPE)
and is the Chairman of the SHAPE Task Force, a non-profit
coalition that helped pass Texas legislation HB1290 as the
first heart attack preventive screening law in the United
States. Dr. Naghavi has over 25 inventions and is passionate
about transforming new ideas into healthcare solutions.
|
 |
|
Ken Walz
Kenneth G. Walz a partner and co-founder of Popper
and Company has spent more than 19 years in the biotech and
medical device industries in business development and finance
roles and has broad experience in the structuring and
negotiation of collaborative arrangements, strategy
development, and financial planning and analysis. At Popper
and Company he assists early stage companies in all aspects of
financial planning, capital raising, and business development
including deal structuring and negotiation. Prior to
co-founding Popper and Company, Mr. Walz was employed as VP
Commercial Development at MDS Proteomics where he led the
negotiation of a $50 million research collaboration with a
leading biopharmaceutical company focused on discovery of
therapeutics to treat diseases of the central nervous system.
Previously, he managed business planning and analysis for
BDGene, a unit of Becton Dickinson & Company. While at
BDGene, he played a lead role in the evaluation of alliance
candidates, creation of a business development strategy, deal
valuation and structuring, and negotiation and closing of
agreements. Mr. Walz earned a Master’s of Science in Finance
from Loyola College of Maryland and a Bachelor of Arts in
Economics from the University of Maryland.
|
 |
|
William Watson
Bill Watson has over 25 years in Marketing, Sales
and Operations of cardiovascular products to hospitals. Over 2
decades as a high-level executive with Sales, Marketing,
Operations, and Management experience. Proven success record
of financial profits and cost management. Served as VP of
Sales & Marketing and VP of Operations for the world’s
largest contract Perfusion services provider. 13 years as a
practicing, certified cardiovascular Perfusionist.
Successfully negotiated 300 outsourced Perfusion &
Autotransfusion agreements in the past 48 months.
|
 |
|
Leo Womack
Leo B. Womack, has been the President and a
director of Gulf Equities Realty Advisors, Inc., a diversified
real estate portfolio management company, since 1986. He has
been and continues to serve as the Executive Chairman of
Fairway Medical Technologies, Inc., a medical device
commercialization company and a portfolio company of the
Baylor College of Medicine Venture Fund since 1996. From 1969
to 1978, Mr. Womack was the managing partner of a local and
later national CPA firm. He has served on the Board of several
public companies and is a past president and Chairman of the
Houston Angel Network. Mr. Womack is licensed as a certified
public accountant, and as a real estate broker. He is also an
active member of NACD the National Association of Corporate
Directors.
|
| |
|
| |
|
